CUAMC
SPRY icon

China Universal Asset Management Company’s ARS Pharmaceuticals SPRY Stock Holding History

China Universal Asset Management Company’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
15,804
-1,737
-10% -$14.9K 0.01% 396
2026
Q1 		$141K Buy
17,541
+1,434
+9% +$13.7K 0.01% 379
2025
Q4 		$188K Sell
16,107
-1,216
-7% -$11.8K 0.01% 348
2025
Q3 		$174K Sell
17,323
-2,403
-12% -$34.5K 0.01% 342
2025
Q2 		$344K Buy
19,726
+232
+1% +$3.35K 0.03% 273
2025
Q1 		$245K Sell
19,494
-1,113
-5% -$13.4K 0.02% 293
2024
Q4 		$217K Buy
20,607
+1,962
+11% +$27.5K 0.02% 319
2024
Q3 		$270K Buy
18,645
+7,262
+64% +$86.4K 0.03% 276
2024
Q2 		$96.9K Sell
11,383
-7,070
-38% -$62.7K 0.01% 303
2024
Q1 		$189K Buy
18,453
+7,348
+66% +$54.8K 0.02% 297
2023
Q4 		$60.9K Buy
11,105
+8,652
+353% +$37.9K 0.01% 347
2023
Q3 		$9.27K Buy
2,453
+1,211
+98% +$7.95K ﹤0.01% 352
2023
Q2 		$8.32K Sell
1,242
-28
-2% -$187 ﹤0.01% 332
2023
Q1 		$8.27K Buy
1,270
+317
+33% +$2.44K ﹤0.01% 318
2022
Q4 		$8.13K Buy
953
+621
+187% +$4.03K ﹤0.01% 247
2022
Q3 		$2K Buy
+332
New +$1.64K ﹤0.01% 359

Other funds holding SPRY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

China Universal Asset Management Company's SPRY Position: Q2 2026 in Review

China Universal Asset Management Company reduced its ARS Pharmaceuticals (SPRY) stake by 9.9% in Q2 2026, selling an estimated $14.9K and leaving 15,804 shares worth $127K. The position accounts for 0.01% of the portfolio, ranked #396.

China Universal Asset Management Company first reported a position in SPRY in Q3 2022 and has held it in 16 quarters since. The position peaked at $344K in Q2 2025. 109 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • China Universal Asset Management Company held 15,804 shares of ARS Pharmaceuticals worth $127K as of Q2 2026.
  • China Universal Asset Management Company sold 1,737 ARS Pharmaceuticals shares in Q2 2026, an estimated $14.9K.
  • ARS Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #396 holding.
  • China Universal Asset Management Company first reported a position in ARS Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's ARS Pharmaceuticals position peaked at $344K in Q2 2025.
  • 109 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.